1      0

eSymposia | Antibodies and Vaccines as Drugs for COVID-19


EK31-eposter-feyisa-mulugeta - Vaccine with novel broad-spectrum immunologic adjuvant to combat COVID-19


Jan 13, 2021 12:00am ‐ Jan 13, 2021 12:00am

Description

Vaccine with novel broad-spectrum immunologic adjuvant to combat COVID-19 Vaccine with novel broad-spectrum immunologic adjuvant which can trigger a wide spectrum of immune cells can be used to provide protection against COVID-19. One of the main challenge for COVID-19 vaccine development is lack approved adjuvants which can induce the required responses. In an attempt to solve this problem, I discovered a novel broad-spectrum immunologic vaccine adjuvant which can exhibit immunomodulatory effects on a wide spectrum of immune cells. A novel broad-spectrum immunologic vaccine adjuvant can enhance immune responses by producing more antibodies, improving the function of the phagocytic cells which destroy viruses and modulating neutrophile and monocytes (macrophages) activity. I have given the name ‘Covid Bullet’ for this broad-spectrum immunologic vaccine adjuvant which have antigen pockets on its surface. Covid-bullet (novel broad-spectrum immunologic vaccine adjuvant) with inactivated SARS-CoV-2 virus on its surface can be used as oral vaccine to provide protection against Covid-19 which is the current global problem. Author: Mulugeta Berhanu, D.V.M Ethiopian Agricultural Transformation Agency

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content